Monitoring Agency Report for the quarter ended March 31, 2026, for Rights Issue.
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Camlin Fine Sciences has received a clean chit from its monitoring agency (India Ratings & Research) for its ₹224.69 crore rights issue completed in January 2025. The entire issue proceeds of ₹22,468.39 lakh have been fully utilized as of March 31, 2026, with no deviations from the stated objects. Of the funds, ₹16,904.93 lakh (about 75%) was deployed for prepayment and repayment of existing borrowings, while ₹5,494.22 lakh was used for general corporate purposes including electricity, salaries, and vendor payments. Issue expenses of ₹69.24 lakh were incurred. This is the final monitoring agency report for this rights issue.
The full utilization of rights issue proceeds for debt repayment signals effective capital deployment, which could improve the company's debt-to-equity ratio and reduce interest costs. This is a positive indicator for shareholders as it strengthens the balance sheet without any deviation from the promised use of funds.